Although chemotherapy may induce a pro-tumorigenic immune response [131], chemotherapeutics also activate the STING (STimulator of INterferon Genes) pathway [132], which induces CCL5 and may thereby induce PD-L1 expression and a tumor immunosuppressive environment [133]. The gene discussed is CCL5; the disease is neoplasm.